{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:40Z","timestamp":1786118800422,"version":"build-2736575974"},"reference-count":71,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004330","name":"Funded by GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2463185","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:12:46Z","timestamp":1741608766000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong Kong"],"prefix":"10.1080","volume":"21","author":[{"given":"Desmond Y. H.","family":"Yap","sequence":"first","affiliation":[{"name":"The University of Hong Kong","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon C. K.","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Chinese University of Hong Kong","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Ho","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S. M.","family":"Wong","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Chan","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor H. F.","family":"Lee","sequence":"additional","affiliation":[{"name":"The University of Hong Kong","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Lam","sequence":"additional","affiliation":[{"name":"Chiron Medical","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip H.","family":"Li","sequence":"additional","affiliation":[{"name":"The University of Hong Kong","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"5","key":"e_1_3_7_2_1","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz R","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR\u20135):1\u201310; quiz CE32-34.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.25.1.170-174.1979"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05648-6"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2176065"},{"key":"e_1_3_7_6_1","unstructured":"Seroprevalence rates of varicella zoster virus antibodies. Hong Kong Department of Health. 2017. [accessed 2023 Dec 20]. https:\/\/www.chp.gov.hk\/en\/statistics\/data\/10\/641\/701\/3691.html."},{"issue":"9","key":"e_1_3_7_7_1","first-page":"123","article-title":"10 FAQs about prevention of herpes zoster for healthcare professionals","volume":"13","author":"Wong TYA","year":"2021","unstructured":"Wong TYA. 10 FAQs about prevention of herpes zoster for healthcare professionals. J Soc Physicians Hong Kong. 2021;13(9):123\u2013128.","journal-title":"J Soc Physicians Hong Kong"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.09.384"},{"key":"e_1_3_7_9_1","unstructured":"AHRQ QI. ICD-10-CM\/PCS specification v2023 prevention quality indicators appendices: Appendix C: Immunocompromised state diagnosis and procedure code. U.S. Department of Health & Human Services. [accessed 2024 Apr 19]. https:\/\/qualityindicators.ahrq.gov\/Downloads\/Modules\/PQI\/V2023\/TechSpecs\/PQI_Appendix_C.pdf."},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy625"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2911"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000339004"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2010.00547.x"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39670"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw205"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa005"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112300"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9090963"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead198"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3118"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020528"},{"key":"e_1_3_7_22_1","unstructured":"Shingrix\u00ae (Herpes Zoster vaccine (recombinant adjuvanted)) [Prescribing Information]. GSK group of companies. 2021 version GDS06."},{"key":"e_1_3_7_23_1","unstructured":"LCQ11: Herpes Zoster. The Government of the Hong Kong Special Administrative Region press releases. 2022. [Accessed 2024 Nov 12]. https:\/\/www.info.gov.hk\/gia\/general\/202205\/04\/P2022050400558.htm."},{"key":"e_1_3_7_24_1","unstructured":"Building a Shingles Atlas for Adult Vaccination Hong Kong. Vaccines 4 Life. 2021. [Accessed 2024 Nov 12]. https:\/\/www.vaccines4life.com\/wp-content\/uploads\/2021\/05\/SAAV_Environmental-Scan_Hong-Kong.pdf."},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1090"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/20587384211002621"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2019.02.009"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.843032"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.978203"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-077644"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa274"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284417"},{"key":"e_1_3_7_33_1","unstructured":"Overview of herpes zoster vaccines. SPH Pharmacy Department. 2021. [Accessed 2023 Dec 20]. https:\/\/www.stpaul.org.hk\/storage\/media\/Doctor%20Zone\/Newsletter\/Newsletter_Issue_109.pdf."},{"key":"e_1_3_7_34_1","unstructured":"Zostavax\u00ae (Live attenuated varicella-zoster virus (Oka\/Merck strain) [Prescribing Information]. [Accessed 2024 Feb 21]. https:\/\/www.mims.com\/hongkong\/drug\/info\/zostavax?type=full."},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.6227"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwac170"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2060668"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.9053"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa424"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30163-X"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31909"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz177"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu606"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41538"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086967"},{"key":"e_1_3_7_46_1","unstructured":"Clinical Considerations for Shingrix Use in Immunocompromised Adults Aged \u226519 Years. Centers for Disease Control and Prevention. Updated 2024 Jul 9. 2022 [Accessed 2023 Dec 18]. https:\/\/www.cdc.gov\/shingles\/hcp\/vaccine-considerations\/immunocompromised-adults.html."},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.021"},{"key":"e_1_3_7_48_1","unstructured":"Immunisation Handbook. Zoster (herpes zoster\/shingles). Ministry of Health - Manatu Hauora. 2020. [Accessed 2023 Dec 18]. https:\/\/www.health.govt.nz\/our-work\/immunisation-handbook-2020\/23-zoster-herpes-zoster-shingles#22-5."},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7103a2"},{"key":"e_1_3_7_50_1","unstructured":"Prevention and treatment of cancer-related infections: Version 1.2023. National Comprehensive Cancer Network. 2023 [Accessed 2023 Dec 18]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/infections.pdf."},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00032"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100548"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1971473"},{"key":"e_1_3_7_54_1","unstructured":"Vaccines for adults with advanced chronic kidney disease kidney failure or kidney transplant. National Kidney Foundation. 2023 [Accessed 2023 Dec 18]. https:\/\/www.kidney.org\/atoz\/content\/vaccinations."},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13622"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223335"},{"key":"e_1_3_7_58_1","unstructured":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Varicella-zoster virus diseases. NIH Office of AIDS Research. 2023. [Accessed 2023 Dec 20]. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/varicella-zoster?view=full."},{"key":"e_1_3_7_59_1","unstructured":"Pharmaceutical Benefits Advisory Committee (PBAC) meeting outcomes: November 2023 PBAC meeting. Australian Department of Health and Aged Care. 2023. [Accessed 2023 Dec 21]. https:\/\/www.pbs.gov.au\/industry\/listing\/elements\/pbac-meetings\/pbac-outcomes\/2023-03\/pbac-web-outcomes-03-2023-v3.pdf."},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1956906"},{"key":"e_1_3_7_61_1","unstructured":"National adult immunization program 2023. Greece Ministry of Health. 2023. [Accessed 2023 Dec 21]. https:\/\/www.moh.gov.gr\/articles\/health\/dieythynsh-dhmosias-ygieinhs\/emboliasmoi\/ethniko-programma-emboliasmwn-epe-enhlikwn\/11251-ethniko-programma-emboliasmwn-enhlikwn-2023?fdl=24972."},{"key":"e_1_3_7_62_1","unstructured":"Free shingles vacscine for people aged 65 and over and immunocompromised people. The Luxembourg Government Ministry of Health. 2023. [Accessed 2023 Dec 21]. https:\/\/msss.gouvernement.lu\/en\/actualites.gouvernement+en+actualites+toutes_actualites+communiques+2023+04-avril+12-vaccin-gratuit-zona.html."},{"key":"e_1_3_7_63_1","unstructured":"GVS advice RZV (Shingrix\u00ae). For the prevention of herpes zoster and related post-herpetic neuralgia. National Health Care Institute. 2021. [Accessed 2023 Dec 21]. https:\/\/english.zorginstituutnederland.nl\/publications\/reports\/2021\/06\/14\/gvs-advice-shingrix."},{"key":"e_1_3_7_64_1","unstructured":"Evaluation of vaccines and vaccination against herpes zoster (Zostavax\u00ae and Shingrix\u00ae). Switzerland Federal Office of Public Health. 2021. [Accessed 2023 Dec 21]. https:\/\/www.bag.admin.ch\/bag\/en\/home\/krankheiten\/krankheiten-im-ueberblick\/windpocken.html#:~:text=EMP_211117_EKIF%20FOPH_Analytic%20Frame%20SHINGRIX_final%20(PDF%2C%201%20MB%2C%2018.11.2021)."},{"key":"e_1_3_7_65_1","first-page":"57","article-title":"Herpes zoster ophthalmicus \u2013 a family physician\u2019s perspective","volume":"23","author":"Kwok SK.","year":"2001","unstructured":"Kwok SK. Herpes zoster ophthalmicus \u2013 a family physician\u2019s perspective. HK Pract. 2001;23:57\u201362.","journal-title":"HK Pract"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25045"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.911520"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac485"},{"key":"e_1_3_7_69_1","unstructured":"A long-term follow-up Study (ZOE-LTFU) of two studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to assess the efficacy safety and immunogenicity persistence of GSK biologicals\u2019 herpes zoster subunit (Hz\/su) vaccine and assessment of 1 or 2 additional doses in two subgroups of older adults. ClinicalTrials.gov. 2024. [Accessed 2024 Nov 12]. https:\/\/clinicaltrials.gov\/study\/NCT02723773?term=NCT02723773&rank=1."},{"key":"e_1_3_7_70_1","unstructured":"Shingrix recommendations. Centers for Disease Control and Prevention. Updated 2024 Oct 22. 2022 [Accessed 2023 Dec 19]. https:\/\/www.cdc.gov\/shingles\/hcp\/vaccine-considerations\/index.html."},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"e_1_3_7_72_1","first-page":"60","article-title":"A pilot study to assess the awareness of herpes zoster and the attitudes towards herpes zoster vaccination among Chinese patients attending a government general out-patient clinic in Hong Kong","volume":"41","author":"Cheng LY","year":"2019","unstructured":"Cheng LY. A pilot study to assess the awareness of herpes zoster and the attitudes towards herpes zoster vaccination among Chinese patients attending a government general out-patient clinic in Hong Kong. HK Pract. 2019;41:60\u201365.","journal-title":"HK Pract"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2463185","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2463185","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2463185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:48:34Z","timestamp":1786034914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2463185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2463185"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2463185","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2463185"}}